Sensorimotor Gating of Schizophrenia Patients Is Influenced by 5-HT2A Receptor Polymorphisms


      Schizophrenia patients exhibit impairment in prepulse inhibition (PPI) of the acoustic startle response (ASR), suggesting a sensorimotor gating deficit. The serotonin-2A receptor (5-HT2AR) has been implicated in both the pathogenesis of schizophrenia and the PPI deficits of schizophrenia patients. Moreover, both schizophrenia and PPI are thought to be inheritable. We investigated the impact of three 5-HT2AR polymorphisms (A-1438G, T102C, H452Y) on PPI in schizophrenia patients.


      We analyzed the 5-HT2AR A-1438G, T102C, and H452Y polymorphisms and assessed startle reactivity, habituation, and PPI of ASR in 68 Caucasian schizophrenia inpatients. Patients were also examined with the Positive and Negative Syndrome Scale.


      The 5-HT2AR A-1438G and T102C polymorphisms were in complete linkage disequilibrium. Patients carrying the T102C TT and the A-1438G AA allele show significantly higher PPI levels and a faster early habituation compared with all other variants. 5-HT2AR A-1438G and T102C genotype explained approximately 11% of the PPI and early habituation variance. In contrast, the 5-HT2AR H452Y polymorphism did not affect startle parameters.


      Our findings suggest that PPI and habituation are modulated by 5-HT2AR A-1438G and T102C genotype in schizophrenia. Consequently, alterations within brain 5-HT2ARs may contribute to the PPI deficits in schizophrenia.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Braff D.L.
        • Geyer M.A.
        • Swerdlow N.R.
        Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies.
        Psychopharmacology (Berl). 2001; 156: 234-258
        • Graham F.K.
        The more or less startling effects of weak prestimulation.
        Psychophysiology. 1975; 12: 238-248
        • Swerdlow N.R.
        • Geyer M.A.
        Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia.
        Schizophr Bull. 1998; 24: 285-301
        • Dean B.
        The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice.
        J Neurochem. 2003; 85: 1-13
        • Meltzer H.Y.
        The role of serotonin in antipsychotic drug action.
        Neuropsychopharmacology. 1999; 21: 106S-115S
        • Abdolmaleky H.M.
        • Faraone S.V.
        • Glatt S.J.
        • Tsuang M.T.
        Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia.
        Schizophr Res. 2004; 67: 53-62
        • Arranz M.J.
        • Munro J.
        • Sham P.
        • Kirov G.
        • Murray R.M.
        • Collier D.A.
        • et al.
        Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response.
        Schizophr Res. 1998; 32: 93-99
        • Golimbet V.E.
        • Lavrushina O.M.
        • Kaleda V.G.
        • Abramova L.I.
        • Lezheiko T.V.
        Supportive evidence for the association between the T102C 5-HTR2A gene polymorphism and schizophrenia: a large-scale case-control and family-based study.
        Eur Psychiatry. 2007; 22: 167-170
        • Spurlock G.
        • Heils A.
        • Holmans P.
        • Williams J.
        • D'Souza U.M.
        • Cardno A.
        • et al.
        A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.
        Mol Psychiatry. 1998; 3: 42-49
        • Sipes T.E.
        • Geyer M.A.
        DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT(2A) and not by 5-HT(2C) receptors.
        Behav Pharmacol. 1995; 6: 839-842
        • Vollenweider F.X.
        • Csomor P.A.
        • Knappe B.
        • Geyer M.A.
        • Quednow B.B.
        The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.
        Neuropsychopharmacology. 2007; 32: 1876-1887
        • Kumari V.
        • Sharma T.
        Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research.
        Psychopharmacology (Berl). 2002; 162: 97-101
        • Tsuang M.
        Schizophrenia: genes and environment.
        Biol Psychiatry. 2000; 47: 210-220
        • Geyer M.A.
        • McIlwain K.L.
        • Paylor R.
        Mouse genetic models for prepulse inhibition: an early review.
        Mol Psychiatry. 2002; 7: 1039-1053
        • Dulawa S.C.
        • Geyer M.A.
        Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice.
        Neuropharmacology. 2000; 39: 2170-2179
        • Willott J.F.
        • Tanner L.
        • O'Steen J.
        • Johnson K.R.
        • Bogue M.A.
        • Gagnon L.
        Acoustic startle and prepulse inhibition in 40 inbred strains of mice.
        Behav Neurosci. 2003; 117: 716-727
        • Cadenhead K.S.
        • Swerdlow N.R.
        • Shafer K.M.
        • Diaz M.
        • Braff D.L.
        Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits.
        Am J Psychiatry. 2000; 157: 1660-1668
        • Anokhin A.P.
        • Heath A.C.
        • Myers E.
        • Ralano A.
        • Wood S.
        Genetic influences on prepulse inhibition of startle reflex in humans.
        Neurosci Lett. 2003; 353: 45-48
        • Greenwood T.A.
        • Braff D.L.
        • Light G.A.
        • Cadenhead K.S.
        • Calkins M.E.
        • Dobie D.J.
        • et al.
        Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia.
        Arch Gen Psychiatry. 2007; 64: 1242-1250
        • Kay S.R.
        • Opler L.A.
        • Fiszbein A.
        Positive and Negative Syndrome Scale (PANSS).
        Multi-Health Systems Inc, North Tonawanda, NY1992
        • Quednow B.B.
        • Wagner M.
        • Westheide J.
        • Beckmann K.
        • Bliesener N.
        • Maier W.
        • et al.
        Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine.
        Biol Psychiatry. 2006; 59: 536-545
        • Kumari V.
        • Gray J.A.
        Smoking withdrawal, nicotine dependence and prepulse inhibition of the acoustic startle reflex.
        Psychopharmacology (Berl). 1999; 141: 11-15
        • Swerdlow N.R.
        • Hartman P.L.
        • Auerbach P.P.
        Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders.
        Biol Psychiatry. 1997; 41: 452-460
        • Ludewig K.
        • Ludewig S.
        • Seitz A.
        • Obrist M.
        • Geyer M.A.
        • Vollenweider F.X.
        The acoustic startle reflex and its modulation: effects of age and gender in humans.
        Biol Psychol. 2003; 63: 311-323
        • Joober R.
        • Benkelfat C.
        • Brisebois K.
        • Toulouse A.
        • Turecki G.
        • Lal S.
        • et al.
        T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability.
        J Psychiatry Neurosci. 1999; 24: 141-146
        • Warren Jr, J.T.
        • Peacock M.L.
        • Rodriguez L.C.
        • Fink J.K.
        An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis.
        Hum Mol Genet. 1993; 2: 338
        • Serretti A.
        • Drago A.
        • De Ronchi D.
        HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies.
        Curr Med Chem. 2007; 14: 2053-2069
        • Polesskaya O.O.
        • Aston C.
        • Sokolov B.P.
        Allele C-specific methylation of the 5-HT2A receptor gene: Evidence for correlation with its expression and expression of DNA methylase DNMT1.
        J Neurosci Res. 2006; 83: 362-373
        • Polesskaya O.O.
        • Sokolov B.P.
        Differential expression of the “C” and “T” alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics.
        J Neurosci Res. 2002; 67: 812-822
        • Parsons M.J.
        • D'Souza U.M.
        • Arranz M.J.
        • Kerwin R.W.
        • Makoff A.J.
        The −1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity.
        Biol Psychiatry. 2004; 56: 406-410
        • Hong L.E.
        • Wonodi I.
        • Stine O.C.
        • Mitchell B.D.
        • Thaker G.K.
        Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition.
        Biol Psychiatry. 2008; 63: 17-23
        • Montag C.
        • Hartmann P.
        • Merz M.
        • Burk C.
        • Reuter M.
        D(2) receptor density and prepulse inhibition in humans: Negative findings from a molecular genetic approach.
        Behav Brain Res. 2008; 187: 428-432
        • Geyer M.A.
        • Braff D.L.
        Startle habituation and sensorimotor gating in schizophrenia and related animal models.
        Schizophr Bull. 1987; 13: 643-668
        • Geyer M.A.
        • Tapson G.S.
        Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors.
        Neuropsychopharmacology. 1988; 1: 135-147
        • Quednow B.B.
        • Kuhn K.U.
        • Stelzenmuelle R.
        • Hoenig K.
        • Maier W.
        • Wagner M.
        Effects of serotonergic and noradrenergic antidepressants on auditory startle response in patients with major depression.
        Psychopharmacology (Berl). 2004; 175: 399-406